BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22344976)

  • 1. The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation.
    Kim J; Wan CK; J O'Carroll S; Shaikh SB; Nicholson LF
    J Neurosci Res; 2012 Jun; 90(6):1136-47. PubMed ID: 22344976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Allmen EU; Koch M; Fritz G; Legler DF
    Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner.
    Riuzzi F; Sorci G; Donato R
    J Cell Sci; 2011 Jul; 124(Pt 14):2389-400. PubMed ID: 21693575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
    Wang L; Li S; Jungalwala FB
    J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
    Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
    J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation.
    Piras S; Furfaro AL; Piccini A; Passalacqua M; Borghi R; Carminati E; Parodi A; Colombo L; Salmona M; Pronzato MA; Marinari UM; Tabaton M; Nitti M
    Neurobiol Aging; 2014 Jun; 35(6):1301-8. PubMed ID: 24484607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
    Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
    Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
    J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
    Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
    Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
    Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
    J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.
    Villarreal A; Aviles Reyes RX; Angelo MF; Reines AG; Ramos AJ
    J Neurochem; 2011 Apr; 117(2):321-32. PubMed ID: 21291473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of expression of sulfoglucuronyl carbohydrate (HNK-1), Amphoterin and RAGE in retinoic acid-differentiated P19 embryonal carcinoma cells.
    Chou DK; Henion TR; Jungalwala FB
    J Neurochem; 2003 Aug; 86(4):917-31. PubMed ID: 12887690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
    Huttunen HJ; Kuja-Panula J; Rauvala H
    J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells.
    Sajithlal G; Huttunen H; Rauvala H; Munch G
    J Biol Chem; 2002 Mar; 277(9):6888-97. PubMed ID: 11739380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons.
    Saleh A; Smith DR; Tessler L; Mateo AR; Martens C; Schartner E; Van der Ploeg R; Toth C; Zochodne DW; Fernyhough P
    Exp Neurol; 2013 Nov; 249():149-59. PubMed ID: 24029001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress.
    Lee BW; Chae HY; Kwon SJ; Park SY; Ihm J; Ihm SH
    Int J Mol Med; 2010 Dec; 26(6):813-8. PubMed ID: 21042774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
    Huttunen HJ; Fages C; Kuja-Panula J; Ridley AJ; Rauvala H
    Cancer Res; 2002 Aug; 62(16):4805-11. PubMed ID: 12183440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.